IC
ImmuCell Corporation
🇺🇸XNAS.ICCCUnited StatesHealthcare
$9.66USDup +0.03 (+0.31%)ClosedDelayed8:30 PM
Price$9.66+0.03 (+0.31%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US4525253062
- CUSIP
- 452525306
Company
- Employees
- 73
- Headquarters
- Portland, United States
- Website
- https://immucell.com
- CEO
- Mr. Paul F. Olivier Te Boekhorst
Market
- Shares outstanding
- 9.1M
- Market cap
- $87.73M
Highlights
- Market cap
- $88.19M
- EPS LTM
- $0.09calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- 111.43calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $30.68M+8.49%up year on year
- Net income
- $787.37K-55.31%down year on year
- Gross margin
- 40.32%+7.68%up year on year
- Free cash flow
- $4.21M+138.91%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.